Guldberg Receives TERMIS-AM Innovation/Commercialization Award

Robert Guldberg, vice president and Robert and Leona DeArmond Executive Director of the Knight Campus, has received the 2026 Innovation/Commercialization Award from the Tissue Engineering and Regenerative Medicine International Society – Americas (TERMIS-AM). 

The award honors outstanding uses of tissue engineering and regenerative medicine that benefit patients.TERMIS describes Guldberg as “an internationally recognized musculoskeletal bioengineer and serial entrepreneur whose research has generated more than 300 publications and six start-up companies.”Guldberg accepted the award today, November 17, at the TERMIS-AM 2026 conference in New Orleans. As part of the ceremony he presented his work to attendees and received a plaque recognizing his career achievements.

Bob Guldberg at lecturn at TERMIS conference receiving innovation and commercialization award on Nov. 17, 2026

Learn more about the TERMIS-AM awards